Revelstoke Completes Divestment of CEI Vision Partners to EyeCare Partners

Revelstoke Completes Divestment of CEI Vision Partners to EyeCare Partners

November 17, 2021

Revelstoke Capital Partners announced that it has sold its CEI Vision Partners investment to EyeCare Partners (ECP) to establish a large integrated vision care network with more than 280 ophthalmologists and 700 optometrists across 18 states, supported by nearly 5,000 clinical staff and 1,200 support services team members.

Since Revelstoke teamed up with Cincinnati Eye Institute to launch CVP in May 2018, nine other ophthalmology practices have joined the platform: Dayton Eye Associates, Retina Physicians & Surgeons, Retina Vitreous Associates, Virginia Eye Consultants, Apex Eye, Virginia Beach Eye Center, Valley Eye Institute, Columbus Ophthalmology Associates, and Tidewater Eye Centers.

CVP has grown to over 150 clinicians across all main ocular subspecialties who deliver high-quality, patient-centered treatment through a network of 47 clinical facilities and eight ambulatory surgical clinics throughout the Midwest and Mid-Atlantic.

“We are proud to have helped CVP develop into one of the premier ophthalmology management service organizations,” said Andrew Welch, Partner at Revelstoke. “We could not have accomplished this without strong alignment of interest and a shared strategic vision with our physician partners and management and employees.”

“In addition to capital, Revelstoke brought significant resources and expertise that enabled CVP to pursue an accelerated, yet disciplined, growth strategy,” said Clyde Bell, Chief Executive Officer of CVP.

“Revelstoke was the clear partner of choice when we embarked on the formation of CVP–they understand how to partner with physicians and have significant experience scaling multi-site provider businesses,” said Daniel Miller, MD, PhD, CVP’s Chief Medical Officer.

“The physicians at CVP are excited to begin our next phase of growth with ECP. This partnership will further our mutual goal of creating the leading integrated eye care company in the U.S.”

Revelstoke rolled over a portion of its proceeds to become an equity holder in ECP alongside lead investor Partners Group, a leading global private markets firm, acting on behalf of its clients.